<DOC>
	<DOCNO>NCT00206739</DOCNO>
	<brief_summary>The purpose study assess effectiveness Intermittent Preventive Treatment Infants ( IPTi ) Sulfadoxine-Pyrimethamine reduce number malaria attack , episode anemia , overall morbidity mortality</brief_summary>
	<brief_title>Intermittent Treatment With Sulfadoxine-pyrimethamine Malaria Control Infants</brief_title>
	<detailed_description>In order define effectiveness Intermittent Preventive Treatment Infants ( IPTi ) Sulfadoxine-Pyrimethamine , novel principle malaria intervention , follow parameter evaluate : ) level protection malaria attack episodes anemia treatment period , ii ) level protection severe malaria treatment period , iii ) effect malaria morbidity sustain treatment , iv ) decrease overall morbidity mortality , include number hospital admission visit hospital outpatient department v ) influence intervention development drug resistance , vi ) impact intervention development immunity , vii ) possible influence intervention sub-clinical organ dysfunction due chronic Plasmodium falciparum infection . Parts study perform collaboration Laboratory Research , Hospital Albert Schweitzer , Lambaréné , Gabon School Medicine Health Sciences , University Development Studies , Tamale , Ghana</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Fanasil , pyrimethamine drug combination</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<criteria>Informed consent parent/guardian ( write oral ) Permanent residentship study area Age 3 month +/4 week Hypersensitivity sulfonamide pyrimethamine ( skin rash , evidence hemolysis include dark urine and/or purpura , presumptive sign bone marrow depression sore throat and/or mouth ulcer ) Other severe adverse event related pyrimethaminesulfadoxine application Signs severe hepatic renal dysfunction due malaria Other reason decision study physician</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>4 Months</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Malaria</keyword>
	<keyword>Anemia</keyword>
	<keyword>IPTi</keyword>
	<keyword>Intermittent Preventive Treatment Infants</keyword>
	<keyword>Sulfadoxine-Pyrimethamine</keyword>
	<keyword>Chemoprophylaxis</keyword>
	<keyword>Ghana</keyword>
</DOC>